Our Pricing

When Do Wegovy Side Effects Start? Complete Dose Guide

Understanding when do wegovy side effects start uk is essential for new patients beginning semaglutide treatment. Most patients experience mild gastrointestinal effects within 24 to 72 hours of their first injection, with symptom intensity typically peaking during dose escalations and subsiding as your body adapts to each new strength [1]. At Cured Pharmacy, our UK clinical team provides comprehensive guidance throughout your Wegovy journey, helping you manage side effects and optimise treatment outcomes.

When Do Wegovy Side Effects Typically Begin?

Wegovy side effects most commonly appear within the first 24 to 72 hours after your initial 0.25mg injection [1]. The majority of patients report mild nausea, reduced appetite, or slight digestive changes during this early window. These initial symptoms reflect semaglutide's mechanism of action — it slows gastric emptying and signals satiety to your brain, which your digestive system needs time to accommodate [2].

In the landmark STEP-1 clinical trial involving 1,961 participants, approximately 44% experienced nausea at some point during treatment, with onset typically occurring within the first week of starting Wegovy or increasing to a new dose [1]. However, severity varies considerably between individuals, and many patients report minimal or no side effects at the lowest starting dose.

It's important to note that side effects don't follow a uniform pattern. Some patients notice symptoms within hours of their first injection, whilst others remain symptom-free for several days or until their first dose escalation. Your individual response depends on factors including your baseline metabolic health, eating habits, and how quickly your body adapts to GLP-1 receptor stimulation.

Wegovy Dose Escalation Schedule and Side Effect Timeline

Wegovy follows a carefully designed dose escalation protocol specifically engineered to minimise side effects whilst optimising weight loss outcomes [2]. The UK-licensed schedule begins at 0.25mg weekly for four weeks, then increases monthly through 0.5mg, 1mg, and 1.7mg, before reaching the maintenance dose of 2.4mg weekly.

Each dose increase represents a critical window when side effects are most likely to resurface or intensify, even if you experienced minimal symptoms at lower doses. Clinical data from the STEP programme shows that gastrointestinal side effects peak within the first week following each escalation, then gradually diminish over the subsequent 2 to 3 weeks as tolerance develops [1][2].

The 0.25mg starting dose rarely produces significant side effects — it serves primarily as a tolerance-building phase. Most patients report their first noticeable symptoms when escalating to 0.5mg or 1mg, with nausea, mild bloating, and reduced appetite being the most common experiences. By the time you reach the 2.4mg maintenance dose, your body has typically adapted to semaglutide's effects, and side effects often become less pronounced or resolve entirely.

Critical Escalation Points to Monitor

The transition from 1mg to 1.7mg represents the most significant dose increase in the Wegovy schedule and is where patients most frequently report intensified side effects. If you experience persistent nausea, vomiting, or difficulty maintaining adequate nutrition at this stage, your UK prescriber may recommend staying at your current dose for an additional month before attempting escalation. This flexible approach, supported by MHRA guidance, helps ensure treatment remains tolerable whilst still delivering clinical benefit [3].

Most Common Wegovy Side Effects and When They Peak

Beyond digestive symptoms, some patients experience fatigue, headache, or dizziness during the first week of treatment or following dose increases. These effects are generally mild and resolve within 5 to 7 days. Injection site reactions — including redness, itching, or mild swelling — may occur but are typically transient and resolve within 48 hours [2].

Rare but serious side effects require immediate medical attention. These include severe persistent abdominal pain (which may indicate pancreatitis), visual changes, or signs of allergic reaction. If you experience any of these symptoms, contact your prescriber or seek urgent medical care immediately. All prescription medications carry risks, and Wegovy requires ongoing clinical monitoring by a UK-registered prescriber to ensure safe, effective use.

Gastrointestinal Effects Timeline

Nausea is the most frequently reported side effect, affecting approximately 44% of patients in clinical trials [1]. It typically begins within 24 to 48 hours of injection, peaks around day 2 to 3, and subsides by day 5 to 6. Diarrhoea and constipation follow similar patterns, though constipation may persist longer, particularly at higher doses. Vomiting occurs less frequently (affecting roughly 24% of patients) but follows the same early-onset timeline [1][2].

These gastrointestinal effects result from semaglutide's action on GLP-1 receptors in your digestive tract, which slows the movement of food from your stomach into your intestines. Whilst uncomfortable, this mechanism is integral to Wegovy's weight loss efficacy — it promotes earlier satiety and reduces overall caloric intake. Most patients find these symptoms become significantly milder or disappear entirely after 3 to 4 weeks at each dose level.

Evidence-Based Strategies to Manage Wegovy Side Effects

Practical dietary modifications can significantly reduce side effect severity, particularly during the first weeks of treatment and following dose escalations. Eating smaller, more frequent meals throughout the day rather than three large meals helps prevent overwhelming your slowed digestive system. Avoiding high-fat, greasy, or heavily spiced foods during the first 72 hours after injection reduces nausea risk, as these foods take longer to digest and may exacerbate GLP-1-related gastric delay [3].

Adequate hydration is essential, particularly if you experience diarrhoea or vomiting. Aim for at least 2 litres of water daily, sipping slowly rather than consuming large volumes at once. Ginger tea, peppermint tea, and small amounts of plain crackers or toast can help settle nausea. If you're experiencing constipation, gradually increasing dietary fibre intake and maintaining physical activity often provides relief without requiring laxatives.

Injection timing can also influence side effect patterns. Many patients find that administering Wegovy in the evening reduces daytime nausea, as peak GLP-1 activity occurs whilst they sleep. However, others prefer morning injections to monitor their response during waking hours. There's no universally correct approach — choose the timing that best fits your schedule and symptom pattern, and maintain consistency week to week.

When to Contact Your Prescriber

Whilst mild side effects are expected and manageable, certain symptoms warrant clinical review. Contact your UK prescriber if you experience persistent vomiting that prevents adequate hydration, severe abdominal pain, visual disturbances, or symptoms of pancreatitis. Your prescriber may recommend temporarily pausing treatment, adjusting your escalation schedule, or exploring alternative weight management options if side effects become intolerable despite management strategies [3].

How Long Do Wegovy Side Effects Last?

For most patients, the acute phase of side effects lasts between 3 to 14 days following each injection, with the most intense symptoms occurring within the first 72 hours [2]. As your body develops tolerance to semaglutide, subsequent injections at the same dose typically produce progressively milder effects. By your third or fourth injection at a given dose level, many patients report minimal or no gastrointestinal symptoms.

However, each dose escalation essentially resets this adaptation process to some degree. When you increase from 0.5mg to 1mg, for example, you may experience a brief return of nausea or digestive changes, even if you'd been symptom-free at the lower dose. This pattern continues through the escalation schedule, though most patients find their overall tolerance improves with each step, and side effects become less disruptive over time.

Long-term data from the STEP trials demonstrates that side effects rarely persist beyond the first 20 weeks of treatment for the majority of patients [1]. By the time you reach and stabilise on the 2.4mg maintenance dose, your body has typically fully adapted to semaglutide's effects. Some patients continue to experience mild appetite suppression or occasional digestive changes, but severe or debilitating side effects are uncommon in long-term use when proper dose escalation protocols are followed.

Starting Wegovy Treatment at Cured Pharmacy

At Cured Pharmacy, Wegovy is available from £79.00 following a free online clinical assessment by our UK-registered prescribers. Our consultation process takes under 3 minutes and evaluates your medical history, current medications, and weight management goals to determine whether Wegovy is clinically appropriate for you. All assessments are conducted by GPhC-registered clinicians, ensuring you receive the same standard of care you'd expect from any UK healthcare provider.

We supply only genuine UK-licensed Wegovy pens manufactured by Novo Nordisk, dispensed by our GPhC-registered pharmacy (registration number 9012511) under the supervision of Superintendent Pharmacist Tarun Kumar (GPhC 2233073). Your medication arrives in 100% discreet packaging with clear instructions for storage, injection technique, and side effect management. We also provide ongoing clinical support throughout your treatment journey — if you have questions or concerns about side effects at any stage, our pharmacy team is available by phone at (+44) 116 4646009.

Starting your Wegovy assessment is straightforward. Complete the brief online consultation, receive prescriber review typically within 24 hours, and have your medication delivered discreetly to your UK address. Our transparent pricing means you'll see the exact cost before completing your consultation — no hidden fees or unexpected charges. All prescription medications require clinical approval by a UK prescriber, and individual results may vary based on adherence to treatment and lifestyle modifications.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
2. Rubino, D., Abrahamsson, N., Davies, M., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224
3. Medicines and Healthcare products Regulatory Agency (MHRA). (2023). Wegovy 0.25 mg solution for injection in pre-filled pen – Summary of Product Characteristics. https://products.mhra.gov.uk/

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and side effects can differ between patients. If you experience severe or persistent side effects, contact your prescriber or seek urgent medical attention immediately.